Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye, has announced the approval of Oxford/AstraZeneca COVID-19 vaccine to be used in Nigeria.
The NAFDAC boss told reporters in Abuja that the vaccine’s capacity to be stored at two to eight degrees centigrade, gave it the edge.
She said that NAFDAC got the dossier of the vaccine a week ago, and the agency’s safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
Three additional vaccines were undergoing evaluation, she said, but that of Astrazeneca indicated that great effectiveness against the UK variant of the virus which has been reported in Nigeria.
Adeyeye, who explained that the South African variant was yet to be reported in Nigeria, disclosed that the agency had over 30 herbal remedies undergoing review for listing, in the treatment of the virus, which was declared since last year as global pandemic by the World Health Organisation (WHO).
The global health institution, had similarly approved the drug for emergency use.
The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine.